OBJECTIVE: To report the rates of mother-to-child transmission (MTCT) of the human immunodeficiency virus (HIV), and the coverage of interventions designed to prevent such transmission, in KwaZulu-Natal. METHODS: Mothers with infants aged ≤ 16 weeks and fathers or legal guardians with infants aged 4-8 weeks who, between May 2008 and April 2009, attended immunization clinics in six districts of KwaZulu-Natal were included. The mothers' uptake of interventions for the prevention of MTCT was explored. Blood samples from infants aged 4-8 weeks were tested for anti-HIV antibodies and, if antibody-positive, for HIV desoxyribonucleic acid (DNA). FINDINGS: Of the 19,494 mothers investigated, 89·9% reported having had an HIV test in their recent pregnancy. Of the 19,138 mothers who reported ever having had an HIV test, 34.4% reported that they had been found HIV-positive and, of these, 13.7% had started lifelong antiretroviral treatment and 67.2% had received zidovudine and nevirapine. Overall, 40.4% of the 7981 infants tested were found positive for anti-HIV antibodies, indicating HIV exposure. Just 7.1% of the infants checked for HIV DNA (equating to 2.8% of the infants tested for anti-HIV antibodies) were found positive. CONCLUSION: The low levels of MTCT observed among the infants indicate the rapid, successful implementation of interventions for the prevention of such transmission. Sampling at immunization clinics appears to offer a robust method of estimating the impact of interventions designed to reduce such transmission. Large-scale elimination of paediatric HIV infections appears feasible, although this goal has not yet been fully achieved in KwaZulu-Natal.
OBJECTIVE: To report the rates of mother-to-child transmission (MTCT) of the human immunodeficiency virus (HIV), and the coverage of interventions designed to prevent such transmission, in KwaZulu-Natal. METHODS: Mothers with infants aged ≤ 16 weeks and fathers or legal guardians with infants aged 4-8 weeks who, between May 2008 and April 2009, attended immunization clinics in six districts of KwaZulu-Natal were included. The mothers' uptake of interventions for the prevention of MTCT was explored. Blood samples from infants aged 4-8 weeks were tested for anti-HIV antibodies and, if antibody-positive, for HIV desoxyribonucleic acid (DNA). FINDINGS: Of the 19,494 mothers investigated, 89·9% reported having had an HIV test in their recent pregnancy. Of the 19,138 mothers who reported ever having had an HIV test, 34.4% reported that they had been found HIV-positive and, of these, 13.7% had started lifelong antiretroviral treatment and 67.2% had received zidovudine and nevirapine. Overall, 40.4% of the 7981 infants tested were found positive for anti-HIV antibodies, indicating HIV exposure. Just 7.1% of the infants checked for HIV DNA (equating to 2.8% of the infants tested for anti-HIV antibodies) were found positive. CONCLUSION: The low levels of MTCT observed among the infants indicate the rapid, successful implementation of interventions for the prevention of such transmission. Sampling at immunization clinics appears to offer a robust method of estimating the impact of interventions designed to reduce such transmission. Large-scale elimination of paediatric HIV infections appears feasible, although this goal has not yet been fully achieved in KwaZulu-Natal.
Authors: Elizabeth M Stringer; Benjamin H Chi; Namwinga Chintu; Tracy L Creek; Didier K Ekouevi; David Coetzee; Pius Tih; Andrew Boulle; Francois Dabis; Nathan Shaffer; Catherine M Wilfert; Jeffrey S A Stringer Journal: Bull World Health Organ Date: 2008-01 Impact factor: 9.408
Authors: N C Rollins; M Dedicoat; S Danaviah; T Page; K Bishop; I Kleinschmidt; H M Coovadia; S A Cassol Journal: Lancet Date: 2002-08-03 Impact factor: 79.321
Authors: Debbie Bradshaw; Mickey Chopra; Kate Kerber; Joy E Lawn; Lesley Bamford; Jack Moodley; Robert Pattinson; Mark Patrick; Cindy Stephen; Sithembiso Velaphi Journal: Lancet Date: 2008-04-12 Impact factor: 79.321
Authors: M P Busch; L L Lee; G A Satten; D R Henrard; H Farzadegan; K E Nelson; S Read; R Y Dodd; L R Petersen Journal: Transfusion Date: 1995-02 Impact factor: 3.157
Authors: Jean H Humphrey; Edmore Marinda; Kuda Mutasa; Lawrence H Moulton; Peter J Iliff; Robert Ntozini; Henry Chidawanyika; Kusum J Nathoo; Naume Tavengwa; Alison Jenkins; Ellen G Piwoz; Philippe Van de Perre; Brian J Ward Journal: BMJ Date: 2010-12-22
Authors: Besigin Tonwe-Gold; Didier K Ekouevi; Ida Viho; Clarisse Amani-Bosse; Siaka Toure; Patrick A Coffie; François Rouet; Renaud Becquet; Valériane Leroy; Wafaa M El-Sadr; Elaine J Abrams; François Dabis Journal: PLoS Med Date: 2007-08 Impact factor: 11.069
Authors: Ayesha B M Kharsany; Cherie Cawood; David Khanyile; Lara Lewis; Anneke Grobler; Adrian Puren; Kaymarlin Govender; Gavin George; Sean Beckett; Natasha Samsunder; Savathree Madurai; Carlos Toledo; Zawadi Chipeta; Mary Glenshaw; Sara Hersey; Quarraisha Abdool Karim Journal: Lancet HIV Date: 2018-07-17 Impact factor: 12.767